CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-12 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +5,250 | 5,250 | ||
| 2020-02-12 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +2,800 | 2,800 | ||
| 2020-02-12 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +2,606 | 2,606 | ||
| 2020-02-12 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +3,000 | 3,000 | ||
| 2020-02-12 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +750 | 750 | ||
| 2020-02-12 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +1,401 | 1,401 | ||
| 2020-02-12 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +15,455 | 15,455 | ||
| 2020-02-12 | DUNBAR GEORGE W JR Director | Returned to the company · Stock Option (Right to Buy) | −5,250 | 0 | ||
| 2020-02-12 | DUNBAR GEORGE W JR Director | Returned to the company · Stock Option (Right to Buy) | −2,800 | 0 | ||
| 2020-02-12 | DUNBAR GEORGE W JR Director | Returned to the company · Stock Option (Right to Buy) | −2,606 | 0 | ||
| 2020-02-12 | DUNBAR GEORGE W JR Director | Returned to the company · Stock Option (Right to Buy) | −3,000 | 0 | ||
| 2020-02-12 | DUNBAR GEORGE W JR Director | Returned to the company · Stock Option (Right to Buy) | −750 | 0 | ||
| 2020-02-12 | DUNBAR GEORGE W JR Director | Returned to the company · Stock Option (Right to Buy) | −1,401 | 0 | ||
| 2020-02-12 | DUNBAR GEORGE W JR Director | Returned to the company · Stock Option (Right to Buy) | −15,455 | 0 | ||
| 2020-02-12 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +23,750 | 23,750 | ||
| 2020-02-12 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 | ||
| 2020-02-12 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +2,500 | 2,500 | ||
| 2020-02-12 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +3,937 | 3,937 | ||
| 2020-02-12 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2020-02-12 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +20,748 | 20,748 |
Page 16 of 24 · 468 trades